Researchers from Queen Mary University of London have identified two new genes that make patients with head and neck cancer resistant to chemotherapy. By suppressing one of these genes, cancer cells that were previously resistant to chemotherapy can now respond to it.
Treatment for over 80 per cent of breast cancer survivors does not end with surgery, radiation, and chemotherapy. Instead, doctors advise them to take medication to inhibit sex hormones, which can fuel tumour growth and cause recurrence, for the next five to ten years.
The researchers shed light on the immune cells' capacity to collectively migrate through diverse environments in their work, which was published today in Science Immunology.
Wilmington (Delaware) [US], August 15: The Chemours Company ("Chemours") (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials, recently announced important achievements in the de
Bengaluru (Karnataka) [India], August 11: Manipal Hospitals, Old Airport Road, today unveiled a specialised day-care centre to create a comfortable and safe set-up for patients undergoing chemotherapy. The centre offers advanced facilities and aims to revolutionise cancer care by providing p
Pune (Maharashtra) [India], July 25: Bone marrow transplants have been a vital treatment option for patients with high-risk blood disorders such as leukemia, lymphoma, and myelodysplastic syndrome (MDS). High-risk blood disorders encompass a group of serious and potentially life-threatening
Researchers discovered a relationship between chemotherapy-induced changes in gut bacteria and the harmful weight gain seen in breast cancer patients, perhaps leading the way to helping survivors avoid obesity-related illness later in life.
The cancer immunotherapy atezolizumab1 significantly increased the overall survival of patients with advanced stage non-small cell lung cancer who were unable to receive platinum-containing chemotherapy when compared to single-agent chemotherapy, according to a global study conducted by UCL
New Delhi [India], July 3: An MoU was signed between Rotary District 3011 and Dr. AV Cancer Institute, Gurugram, to collaborate in providing preventive medical services for Cancer Screening and providing day-care Chemotherapy facilities at subsidized charges for people recommended by Rotaria